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Simian retroviruses (SRVs), the etiological agent of a spontaneous Simian acquired immunodeficiency syndrome, endem-
ically infects large percentages of Asian macaques housed in biomedical research colonies and severely compromises the
effective use of these species as a viable research animal. We recently described the molecular cloning of a serogroup 2 SRV,
D2/RHE/OR, which causes mild immunosuppression in rhesus macaques. A restriction site variant, D2/RHE/OR/V1, has also
been recovered from severely ill animals endemically infected with D2/RHE/OR. We now report the complete nucleotide
sequences of D2/RHE/OR and D2/RHE/OR/V1. Both infectious molecular clones retain the genetic structure typical of type
D SRVs (59 LTR-gag-prt-pol-env-39LTR) and encode identically sized 8105-bp proviruses. D2/RHE/OR and D2/RHE/OR/V1 are
99.3% similar at the amino acid level, exhibiting only 17 residue differences, of which 10 are located in the envelope
glycoproteins. The molecular clones and reciprocal chimeric viruses were used to assess the contribution of different
genetic domains to virus infectivity in a T cell infection assay. These experiments indicate that D2/RHE/OR has a reduced
ability to infect specific T cell lines, especially Hut-78 and MT-4 cells, and that the envelope gene is not the sole determinant
of in vitro tropism. © 1999 Academic Press
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Nearly 30 years have passed since the first type D
etrovirus was originally isolated and characterized from
breast carcinoma of an 8-year-old female rhesus ma-
aque (Macaca mulatta) (Jensen et al., 1970; Chopra and
ason, 1970). Several unsuccessful attempts had been
ade to verify the oncogenic nature of this virus, identi-
ied as Mason-Pfizer monkey virus (MPMV), by inoculat-
ng rhesus macaques (Fine et al., 1972, 1975). Although
PMV did not induce breast carcinomas in these ani-
als, inoculated neonatal rhesus macaques did develop
n immunosuppressive disease characterized by severe
ymphadenopathy, weight loss, thymic atrophy, and op-
ortunistic infections (Bryant et al., 1986a; Henrickson et
l., 1983; Arthur et al., 1986; Fine et al., 1975). Since the
nitial discovery of MPMV, four additional Simian retrovi-
us (SRV) serogroups have been recovered from multiple
acaque species exhibiting varying degrees and symp-
oms of spontaneous immunosuppressive disease (Hei-
ecker et al., 1987; Maul et al., 1986; Benveniste et al.,
985; Letvin et al., 1984; Shiigi et al., 1986).
1 To whom reprint requests should be addressed at Division of
euroscience, Oregon Regional Primate Research Center, Oregon
ealth Sciences University, 505 NW 185th Avenue, Beaverton, OR
7006. Fax: (503) 690-5384. E-mail: machidac@ohsu.edu.
43The five serogroups of type D SRVs are distinguished
y neutralization assays. Serogroup 1 SRVs (SRV-1) were
haracterized at the New England and California Re-
ional Primate Research Centers (RPRCs). The D1/
YC/NE isolate was recovered from a Taiwanese rock
acaque (Macaca cyclopis) (Daniel et al., 1984). The
alifornia isolate, D1/RHE/CA, was recovered from a
hesus macaque (M. mulatta) and is associated with
ore severe immunodeficiency than the D1/CYC/NE iso-
ate (Marx et al., 1984; Henrickson et al., 1983; London et
l., 1983). Serogroup 2 viruses have been identified at the
ashington (D2/MNE/WA) and Oregon (D2/CEL/OR, D2/
HE/OR) RPRCs and have been associated with retro-
eritoneal fibromatosis (RF) in some macaque species
Celebes, pig-tailed, and cynomolgus), in addition to Sim-
an acquired immunodeficiency syndrome (SAIDS) (Gid-
ens et al., 1985; Shiigi et al., 1986; Benveniste et al.,
985; Stromberg et al., 1984; Marx et al., 1985). The
riginal MPMV and D3/RHE/WI, isolated at the Wiscon-
in RPRC, belong to serogroup 3 (Sonigo et al., 1986).
ingle members of serogroups 4 (D4/CYN/CA) and 5
D5/RHE/OR) have been recovered from a group of cyno-
olgus macaques in Berkeley, CA, and from rhesus
acaques imported from the People’s Republic of China
o the Oregon RPRC, respectively (M. A. Axthelm, per-
onal communication).Four different serogroup 2 SRVs have been character-
0042-6822/99 $30.00
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44 MARRACCI ET AL.zed at the Oregon RPRC. Although they are related by
erology, each of the four isolates is characterized by
nique restriction site polymorphisms. Besides the
elebes (D2/CEL/OR) and rhesus (D2/RHE/OR) isolates
escribed above, two additional serogroup 2 SRVs have
een identified at the Oregon RPRC. One variant, D2/
HE/OR/V1, was isolated from a severely ill rhesus ma-
aque originating from group-housed animals endemi-
ally infected with D2/RHE/OR. Transmission studies
erformed at the Oregon RPRC have demonstrated that
hesus macaques infected with the Celebes isolate (D2/
EL/OR) seroconvert and become aviremic without man-
festing any measurable symptoms of disease (Marx et
l., 1985). D2/RHE/OR is associated with a mild immu-
odeficiency disease in rhesus macaques and is thought
o be similar to the Washington RPRC isolate, D2/MNE/
A, recovered from a pig-tailed macaque (Macaca nem-
strina) (Henderson et al., 1985; Grant et al., 1995a,
995b). However, D2/RHE/OR-infected Japanese ma-
aques (Macaca fuscata) developed severe, fatal immu-
odeficiency disease. A second variant, D2/CYN/OR/V2,
as recovered from cynomolgus macaques (Macaca
ascicularis) with severe immunodeficiency disease.
The differences in pathogenic outcome associated
ith the serogroup 2 SRV family is intriguing given the
igh degree of genetic similarity between the different
solates (Marx et al., 1985; Bryant et al., 1986; Thayer et
l., 1987). Small alterations in nucleotide sequence iden-
ified among viruses with a high degree of similarity have
een demonstrated to invoke significant differences in
iological behavior. A domain spanning the tRNA primer
inding site of Moloney murine leukemia virus has been
hown to inhibit productive infection in F9 embryonal
arcinoma cells but not differentiated NIH 3T3 cells (Loh
t al., 1988). Differences in gag gene sequence can
elease Moloney murine leukemia virus from restricted
eplication that is imposed by the Fv1 locus in certain
arget cells (Goff and Lobel, 1987; Kozak and Chakraborti,
996; Ou et al., 1983; DesGroseillers and Jolicoeur, 1983).
lterations in the amino acid sequence of the HIV env
lycoproteins, which lead to an overall positive (basic)
et charge of the V3-loop, can facilitate use of the CXCR4
oreceptor and replication in T lymphocytes (Fouchier et
l., 1992; Cocchi et al., 1996). SRV-1 from the New En-
land RPRC was demonstrated to infect human B cells
Raji); in contrast, SRV-1 from the California RPRC readily
nfected both human B and T cell lines in vitro (Maul et
l., 1988; Yetz and Letvin, 1987). To better characterize
he serogroup 2 SRVs isolated at the ORPRC, we isolated
nd sequenced full-length infectious molecular clones of
2/RHE/OR and D2/RHE/OR/V1. In addition, reciprocal
himeric viruses were constructed to analyze the contri-
utions made by genomic determinants to in vitro infec-
ivity of lymphoid cell lines that may be reflective of the
ariations observed in pathological outcome. wRESULTS
ibrary construction and the isolation of a full-length
nfectious D2/RHE/OR/V1 molecular clone
The D2/RHE/OR/V1 molecular clone was derived from
genomic DNA library generated from infected Raji cell
NA. Infectivity was determined by transfection of ca-
ine D-17 cells followed by cocultivation with permissive
aji cells to rescue and amplify the virus population (see
aterials and Methods). Raji cells, cocultivated with D17
ells transfected with the D2/RHE/OR/V1 lambda clone
11B-V1), were env gp20 immunofluorescence positive in
5.4% of the population (Fig. 1E). Culture medium from
he 11B-V1 cocultures were filtered and transferred to
resh Raji cells; 96.7% of the Raji population became
ositive for gp20 expression (Fig. 1F). All negative control
ultures, including uninfected Raji cells (Fig. 1A), mock-
ransfected cocultures (Fig. 1C), and medium transfer
xperiments from mock-transfected cocultures (Fig. 1D)
isplayed 0% gp20 immunofluorescence. In addition to
etection of gp20 expression, productive infection was
emonstrated by the presence of syncytia and electron
icroscopic visualization of virions (unpublished data).
ll infection criteria were met, thereby confirming trans-
ission of infection by cell-free virus from transfected
ell culture fluid.
All serogroup 2 SRVs can be distinguished by an
coRI restriction enzyme polymorphism; with the excep-
ion of D2/RHE/OR/V1, an EcoRI site in the pol gene is
resent in their viral genomes. Southern analyses, using
NA from molecular clone infected Raji cocultures (de-
cribed in Fig. 1) and from cells infected with a biological
2/RHE/OR/V1 isolate, displayed identical restriction
ragment patterns. The absence of the pol EcoRI site in
he genome of the molecular clone is consistent with its
dentification as D2/RHE/OR/V1 (unpublished observa-
ions).
In addition, the full-length D2/RHE/OR/V1 genome has
een subcloned into the plasmid pBR322 using HindIII
estriction sites that are located in the human flanking
NA. The D2/RHE/OR/V1 plasmid clone, designated pV1,
as been demonstrated to be equivalent to the parental
ambda clone by restriction endonuclease digestion,
outhern, and infection analyses. The pV1 molecular
lone was then used as a template for sequence analy-
es and for the generation of infectious virus used in
tudies reported here.
ucleotide sequences of the D2/RHE/OR and D2/
HE/OR/V1 proviruses
D2/RHE/OR/V1 was first isolated from a rhesus ma-
aque endemically infected with D2/RHE/OR and af-
licted with severe immunodeficiency. Sequencing the
omplete genomes of D2/RHE/OR and D2/RHE/OR/V1
as performed to further characterize the genetic vari-
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45POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVsbility of these two serogroup 2 polymorphic isolates and
o identify genetic domains that may influence the infec-
ivity of the virus in vitro.
The D2/RHE/OR and D2/RHE/OR/V1 viruses retain the
enetic structure of type D SRVs (59-LTR-gag-prt-pol-env-
FIG. 1. Detection of env gp20 in D2/RHE/OR/V1-infected Raji cells.
ACS analyses, using anti-SRV env gp20 monoclonal antibodies, were
onducted on several experimental and control Raji cell lines. The
anels represent env gp20 expression in (A) uninfected Raji cells, (B)
ositive-control SRV 2-infected Raji cells, (C) Raji cells cocultivated with
ock transfected D-17 cells, (D) Raji cells inoculated with filtered
ulture medium obtained from the mock-transfected cocultures, (E) Raji
ells cocultivated with D17 cells transfected with the D2/RHE/OR/V1
ambda clone (11B-V1), or (F) Raji cells inoculated with filtered culture
edium from 11B-V1-transfected cocultures. The percentage of posi-
ively stained cells, recognized above threshold values, are shown in
he top right corner of each histogram. FACS analyses conducted with
hese six cell lines, using negative control IgG2a monoclonal antibod-
es, were below background (unpublished observations).9-LTR) and encode identically sized 8105 bp proviruses pFig. 2). The gag, prt, pol, and env genes encode the viral
ore proteins, viral protease, reverse transcriptase/endo-
uclease/integrase, and envelope glycoproteins, respec-
ively. As in other molecularly cloned type D SRVs
Thayer et al., 1987; Sonigo et al., 1986; Power et al.,
986), the gag, prt, and pol genes contained in both
2/RHE/OR and D2/RHE/OR/V1 are overlapping and are
redicted to generate the Pr78, Pr95, and Pr180 precur-
or polyproteins, respectively (Bradac and Hunter, 1984).
equence variability between D2/RHE/OR and D2/RHE/
R/V1 is restricted to nucleotide substitutions. All nucle-
tide sequence or deduced amino acid comparisons
tated in the text will use D2/RHE/OR/V1 as the refer-
nce sequence unless otherwise noted.
ong terminal repeat and intergenic spacer regions
Retroviral long terminal repeats (LTRs) contain critical
equences necessary for the integration, synthesis, and
xpression of viral DNA (Vaishnav and Wong-Staal, 1991;
onigo et al., 1986). Both D2/RHE/OR and D2/RHE/OR/V1
enomes contain identical LTRs of 346 bp. The D2/
HE/OR and D2/RHE/OR/V1 LTRs are 96.2, 73.3, and
6.0% conserved to corresponding sequences in D2/
EL/OR, D1/RHE/CA, and MPMV, respectively. The U3
TGTCC) and the U5 (GGACA) inverted repeats found in
he LTRs of both D2/RHE/OR and D2/RHE/OR/V1 are
recisely conserved in both sequence and location with
orresponding D2/CEL/OR, D1/RHE/CA, and MPMV se-
uences. Identical candidate TATA boxes have been
dentified in the 59 LTRs of both D2/RHE/OR and D2/RHE/
R/V1 (TATATA); slight sequence variations in the TATA
lement have been observed in D1/RHE/CA and in
PMV (TATATAA). Potential polyadenylation signals (po-
itions 7991–7996) have been identified in D2/RHE/OR
nd D2/RHE/OR/V1; these signals are identical among
he molecularly cloned SRVs, D2/CEL/OR, D1/RHE/CA,
nd MPMV. Interestingly, this potential polyadenylation
ignal (ATTAAA) is different from those (AATAAA) most
ommonly found in eukaryotic genes and viruses (Proud-
oot and Brownlee, 1974).
he gag gene
Both D2/RHE/OR and D2/RHE/OR/V1 contain gag
pen reading frames (ORF) of 659 codons, with a pre-
icted translation product of 654 amino acids. The Pr78
ag precursor is proteolytically processed to form six
ature virion core proteins in the following order: NH2-
10, pp24/pp18, p12, p27, p14, p4 (Henderson et al., 1985;
radac and Hunter, 1984). Overall, the D2/RHE/OR and
2/RHE/OR/V1 gag polyproteins are 96.2 and 96.3% con-
erved, respectively, relative to corresponding se-
uences found in D2/CEL/OR, and 83.6% conserved rel-
tive to the gag polyproteins found in both D1/RHE/CA
nd MPMV. Moreover, serogroup 2 SRVs encode a larger
hosphoprotein than MPMV, with an N-terminus starting
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46 MARRACCI ET AL.t gag residue 101; MPMV has an N-terminus gag resi-
ue at position 160, resulting in a phosphoprotein of 18
Da (Henderson et al., 1985; Sonigo et al., 1986). The
east conserved peptide of the gag polyprotein among all
olecularly cloned SRVs is the pp24/pp18 phosphopro-
ein; the most highly conserved is the major capsid
eptide, p27. The D2/RHE/OR and D2/RHE/OR/V1 gag
enes are highly conserved, exhibiting only three de-
uced amino acid differences of 654 residues (Fig. 3).
hese three nonconservative differences are located
ithin the phosphoprotein (pp24/pp18) at positions 127
D2/RHE/OR/V1 to D2/RHE/OR; Thr to Met), 182 (Glu to
ys), and 205 (Arg to Gly). Amino-terminal protein se-
uence analysis has determined the first 32 residues of
he D2/MNE/WA gag phosphoprotein and has identified
hanges at positions 117 (D2/RHE/OR/V1 to D2/MNE/
A; Asp to Gln), 125 (Lys to Ser), and 127 (Thr to Met)
Henderson et al., 1985). Interestingly, although the gag
27 is 100% conserved between D2/RHE/OR and D2/
HE/OR/V1, the D2/MNE/WA p27 has a single noncon-
erved residue at position 353 (D2/RHE/OR/V1 to D2/
NE/WA; a small, nonpolar Ala to a polar Thr), which is
etained in D2/CEL/OR, D1/RHE/CA, and MPMV (amino
cid residues 351–490 of D2/MNE/WA were deduced
rom nucleotide sequence analysis) (Grant et al., 1995b).
he prt gene
The D2/RHE/OR/V1 and D2/RHE/OR viral protease is
ncoded by the prt ORF, which overlaps gag by 61
odons and pol by 8 codons. The resulting frameshift
ould produce a polyprotein with a deduced molecular
ass of 97 kDa, consistent in size with the second
ag-associated precursor (Pr95) observed in MPMV. The
2/RHE/OR/V1 and D2/RHE/OR prt genes both encode
FIG. 2. Schematic diagram of the D2/RHE/OR/V1 genome. The top
estriction endonuclease sites and locations are depicted. The horizon
ene (gag, prt, pol, and env) and the relative reading frame. Arrows on
he same line depict translations using the same reading frame. Numb
he nucleotide sequence of the complete genome. The ORF diagrams
or D2/RHE/OR/V1 and D2/RHE/OR have been deposited at GenBankroteins containing 314 amino acids that are 99.7% con- served at the amino acid level; a single change is ob-
erved at position 98 (D2/RHE/OR/V1 to D2/RHE/OR;
olar Gln to nonpolar Leu) (data not shown). Predictably,
he D2/RHE/OR/V1 prt product is 98.4% conserved to
orresponding amino acid sequences in D2/CEL/OR
ith only five amino acid differences at positions 117
D2/RHE/OR/V1 to D2/CEL/OR; Lys to Arg), 135 (Ile to
al), 153 (Asn to Asp), 169 (Asn to His), and 307 (Asn to
sp). In addition, the D2/RHE/OR/V1 prt is 82.8 and 83.8%
onserved to comparable proteins encoded by D1/
HE/CA and MPMV, respectively.
he pol gene
A second frameshift within the prt–pol overlap would
enerate a 200-kDa polyprotein encoding gag, prt, and
ol sequences, in agreement with the observed molec-
lar weight of the third gag-associated precursor (Pr180)
bserved in MPMV (Bradac and Hunter, 1984). The pol
enes of all molecularly cloned type D SRVs encode
redicted products exhibiting two functional domains:
he reverse transcriptase and endonuclease/integrase
omains. Deduced amino acid sequence similarity to the
ol of Rous sarcoma virus predicts that this protein may
e enzymatically processed near amino acid 593,
hereby releasing the reverse transcriptase from the en-
onuclease/integrase domain (Hippenmeyer and Grand-
enett, 1984). This putative processing site is conserved
mong all molecularly cloned serogroup 2 SRVs (Thayer
t al., 1987). The product of the D2/RHE/OR/V1 pol gene
s 99.7% similar to that of D2/RHE/OR with three differ-
nces at positions 111 (D2/RHE/OR/V1 to D2/RHE/OR;
eu to Pro), 151 (Met to Ile), and 337 (Leu to Phe); the
2/RHE/OR/V1 pol product is closely related to corre-
m denotes a partial restriction map of the D2/RHE/OR/V1 genome.
ws in the lower diagram denote the extent of translation for each viral
te lines depict translations using different reading frames; arrows on
r to the start and stop codon positions for each translation, relative to
RHE/OR/V1 and D2/RHE/OR are equivalent. The complete sequences
cession numbers AF126468 and AF126467, respectively.diagra
tal arro
separa
ers refe
for D2/ponding sequences in D2/CEL/OR (97.3%) and less re-
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47POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVsated to MPMV and D1/RHE/CA (82.7 and 84.1%, respec-
ively) (data not shown).
he env gene
The env genes of all three cloned serogroup 2 SRVs
D2/RHE/OR, D2/RHE/OR/V1, and D2/CEL/OR) encode
lycoproteins of 574 amino acid residues (Fig. 4). All
hree envelope glycoproteins contain 22 cysteine resi-
ues and 11 conserved Asn-X-Ser(Thr) glycosylation
ites. The D2/RHE/OR and D2/RHE/OR/V1 envelope gly-
oproteins are 98.3% similar overall at the amino acid
evel and 98.4 and 97.9% similar within the extrinsic gp70
nd transmembrane gp20 regions, respectively. The hy-
FIG. 3. Comparison of the gag polyprotein of D2/RHE/OR/V1 with
orresponding gene products encoded by D2/RHE/OR, D2/CEL/OR, D2/
y lowercase letters; dots represent identical residues. The major ho
ucleocapsid are underlined. For D2/MNE/WA sequence determined byrophobic and heptad-repeat domains at the gp20 N- terminus (amino acid residues 410–458) are present and
ell conserved in all molecularly cloned SRVs, including
2/MNE/WA (Chambers et al., 1990; Grant et al., 1995b).
en amino acid residue substitutions are found between
he D2/RHE/OR and D2/RHE/OR/V1 glycoproteins; of
hese, three appear to be conserved between D2/
HE/OR and D2/CEL/OR and are located at residues 302
D2/RHE/OR/V1 to D2/RHE/OR or D2/CEL/OR; a small,
onpolar Gly to a charged Asp), 316 (a bulkier Ile to a
olar Thr), and 415 (a conservative change from Arg to
ys). The immunosuppressive peptide found at residues
47–472 is identical among all molecularly cloned SRVs,
ith the exception of D2/RHE/OR, which varies at posi-
SRVs. The gag protein of D2/RHE/OR/V1 was compared with the
A, D1/RHE/CA, and MPMV. Amino acid residue changes are indicated
region of the p27 capsid protein and the two Cys-His motifs of the
et al. (1995a, 1995b) and Henderson et al. (1985), x 5 could not identify.other
MNE/W
mologyion 455 (D2/RHE/OR/V1 to D2/RHE/OR; Leu to Phe) (Fig.
4
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48 MARRACCI ET AL.) (Grant et al., 1995b; Cianciolo et al., 1984). The partial
p70 sequence (residues 144–259) and the complete
p20 domain of D2/MNE/WA have also been compared
ith the serogroup 2 SRVs found at the Oregon RPRC
Grant et al., 1995a, 1995b). Interestingly, the D2/MNE/WA
nd D2/RHE/OR/V1 isolates share three amino acid res-
dues (Ala404, Leu455, and Gly519) within the gp20 domain
hat are distinct from D2/RHE/OR (Thr404, Phe455, and
rg519). Except for a Leu-to-Phe difference at position 446
within a heptad-repeat of the gp20 domain), the remain-
FIG. 4. Comparison of the env glycoprotein of D2/RHE/OR/V1 wit
orresponding gene products encoded by D2/RHE/OR, D2/CEL/OR, D2/
y lowercase letters; dots represent identical residues. The cleavage s
n asterisk. The amino acids of the heptad repeat region in the fusion
cid residues 446–477 and is underlined. The membrane spanning dom
s from amino acid residue 554–566 with the His-Tyr cleavage site italic
enderson et al. (1985), 1 5 D, E, N, or Q; 2 5 I or V.ng D2/MNE/WA amino acid differences are conservative 5ith respect to polarity, charge, and bulk when compared
ith D2/RHE/OR/V1 sequence (Fig. 4).
onstruction of reciprocal chimeric viruses and
nalysis of determinants of in vitro infection
f lymphoid cell lines
The chimeric viruses, p59V1392R and p592R39V1, con-
ain reciprocal combinations of the 59 and 39 halves of
2/RHE/OR and D2/RHE/OR/V1. p59V1392R contains the
r SRVs. The env protein of D2/RHE/OR/V1 was compared with the
A, D1/RHE/CA, and MPMV. Amino acid residue changes are indicated
ween the envelope gp70 (SU) and gp20 (TM) domains is indicated by
are italicized. The immunosuppressive peptide domain is from amino
between amino acid residues 518–546. The gp22 processing domain
or the D2/MNE/WA sequence determined by Grant et al. (1995a,b) andh othe
MNE/W
ite bet
domain
ain lies
ized. F9 half of D2/RHE/OR/V1 and the 39 half of D2/RHE/OR.
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49POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVs592R39V1 contains the 59 half of D2/RHE/OR and the 39
alf of D2/RHE/OR/V1. These recombinants were con-
tructed in a pBR322 backbone (see Materials and Meth-
ds), and the chimeric nature of these clones was veri-
ied by polymerase chain reaction (PCR), restriction en-
onuclease digestion, and sequence analyses (data not
hown). By using a unique BamHI restriction endonucle-
se site in the pol gene (nucleotide position 4593), we
ere able to segregate the amino acid differences be-
ween the env gene in the 39 half and the gag-prt-pol
enes in the 59 half of both viral genomes. Infectivity for
ach chimeric virus was determined by transfection of
anine D17 cells followed by rescue and amplification in
aji cells, as described above. Criteria for successful
nfection were defined by syncytia formation in the Raji
ell culture, gp20 expression, and the transmission of
nfection using cell-free virus from filtered (0.45 mm)
ransfection culture fluid (data not shown). All criteria of
nfection were met, and the infectious chimeric viruses
ere then used to determine the role of the different
enetic domains in in vitro infection of lymphoid cell
ines.
A battery of T cell lines, CEM-SS, Hut78, MT-4, and
upT-1, in addition to Raji cells (a B cell line used as a
ositive control), were targets for infection by molecularly
loned viruses D2/RHE/OR and D2/RHE/OR/V1 and the
eciprocal chimeric viruses p59V1392R and p592R39V1.
everse transcriptase assays of cell-free culture medium
ere performed to determine the equivalent viral loads
sed to infect fresh cells. The extent of infection was
ssessed by monitoring env gp20 expression; uninfected
ultures for each cell line and an infected Hut78 culture
ere used as the negative and positive assay controls,
espectively. Immunofluorescence assays for gp20 ex-
ression were repeated at weekly intervals after the first
ositive measurement to verify virus infection. The cur-
ent infection experiments were designed to continue for
p to 60 days.
Three reproducible patterns of infection were ob-
erved using cell-free inoculation of the different T and
cell lines. The first pattern of gp20 expression is
haracterized by rapid infection (.50% by days 10–16)
nd a retention of gp20 expression over time. This
attern of infection kinetics was observed in Raji and
EM-SS cell lines infected with D2/RHE/OR/V1 and
2/RHE/OR and the chimeric viruses p592R39V1 and
59V1392R, as well as in MT-4 cells infected by D2/
HE/OR/V1, p592R39V1, and p59V1392R (Figs. 5A, 5C,
nd 5E). In addition, D2/RHE/OR/V1- and p592R39V1-
nfected Raji cells formed numerous large and bal-
ooning syncytia, whereas infection with D2/RHE/OR
r p59V1392R in the same cell line formed very few and
mall syncytia (data not shown). The syncytia forming
apacity of each viral clone was reproducible and
ppeared to be independent of gp20 expression in theemaining cell lines (data not shown). pThe second pattern of infection was characterized by
apid infection (.50% by day 10), followed by a decrease
n the percentage of gp20 expressing cells (from a range
f 84–99% at day 10 to 14–45% after 24 days; Fig. 5D).
oreover, after the first 10 days of infection, the greatest
ilution of cell-free culture medium still capable of form-
ng syncytia was unusually high but deteriorated over the
ourse of the study (data not shown). This pattern of
p20 expression was unique to infection of SupT1 cells
nd was observed after infection with all the virus
lones. Due to the infection kinetics observed in Fig. 5D,
e extended the observation period for infection of
upT-1 cells for an additional week in a subsequent
xperiment to determine whether the levels remained
epressed. We observed a rebound from a range of
0–70% of the population infected at day 24 to 81–97% at
ay 31 for each of the viruses tested (data not shown).
his novel pattern of infection and gp20 expression has
ot been observed before in our infection assays. Inter-
stingly, the level of syncytia forming units released by
nfected SupT-1 cultures remained relatively high, even
ith a depressed gp20 expression value (data not
hown).
The third pattern of infection was defined by a delayed
nset of viral gp20 expression, with retention of env
xpression in the population over time. This pattern of
p20 expression was observed in MT-4 cells infected
ith the D2/RHE/OR virus. In Fig. 5C, gp20 expression in
2/RHE/OR-infected MT-4 cells was negligible at day 24;
nly after prolonged incubation periods did we observe
n increase in gp20 expression (37% infected after 38
ays and 80% infected after 45 days in culture; data not
hown). A similar delay in gp20 expression was also
ocumented in a subsequent experiment; D2/RHE/OR
p20 expression in MT-4 cells did not reach 95% until
ay 24, as much as 2–3 weeks after all other viruses
D2/RHE/OR/V1, p592R39V1, and p59V1392R) had maxi-
ally infected this same cell line (data not shown). As
an be seen in Fig. 5B, infection of the Hut78 cell line by
2/RHE/OR was markedly reduced as defined by gp20
xpression. Failed infection of Hut 78 cells by D2/
HE/OR was confirmed by lack of virus transmissibility
hen cell-free Hut 78 culture medium was overlaid onto
ensitive Raji cells; these Raji cells did not exhibit syn-
ytia and were PCR negative for amplification of SRV
rovirus (data not shown). However, in some experi-
ents after an extended period of culture, the D2/
HE/OR molecular clone exhibited a delayed onset of
ositive gp20 expression (data not shown). Interestingly,
ach of these five different cell lines were exposed to the
ame infectious titer of D2/RHE/OR clone virus, yet in-
ections varied from as few as 10 days to as many as 45
ays before reaching near-maximum levels of gp20 ex-
ression within the population.
i
s
l
p
s
c
p
w
m
i
s
T
n
1
H
r
w
p
t
t
c
M
a
a
H
g infectio
50 MARRACCI ET AL.DISCUSSION
Serogroup 2 SRVs are the most frequent type D virus
solates found in U.S. macaque colonies, regardless of
pecies. In addition, serogroup 2 SRVs have been iso-
ated from M. fascicularis obtained from wild Indonesian
opulations (Thouless et al., 1988). Studies in India, the
ource of founder animals for most of the rhesus ma-
aques held in biomedical research colonies, failed to
rovide serological evidence of type D SRV infection in
ild populations of rhesus and bonnet macaques. Thus
FIG. 5. Cell-free infection of different human T cell lines by SRV-2 vi
he parental SRV-2 molecular clones (D2/RHE/OR and D2/RHE/OR/V1)
ell-free inocula was normalized for RT activity. Cultures were monitore
ock cultures of all experimental cell lines and an infected Hut cell line
nd positive, respectively (data not shown). Two independent experimen
single experiment. The following graphs are representative of the in
ut78 cell infection, (C) MT-4 cell infection, (D) SupT-1 cell infection, a
p20 analysis after day 31; Hut78 cells were negative for D2/RHE/ORost rhesus macaques appear to harbor SRVs originat- (ng from Indonesian populations. Natural reservoirs for
erogroups 1, 3, 4, and 5 SRV have not been identified.
he potential role of type D retroviral infection in immu-
odeficiency in humans is controversial (Morozov et al.,
991; Kzhyshkowska et al., 1996; Krause et al., 1989;
eneine et al., 1993). However, putative human type D
etroviruses have been isolated from an AIDS patient
ith an atypical variant of a Burkitt’s-type B cell lym-
homa (Bohannon et al., 1991) and more recently from
he salivary glands of patients with Sjogren’s syndrome
es. Infection of the T cell lines CEM-SS, Hut 78, MT-4, and SupT-1 by
ciprocal chimeras (p592R39V1 and p59V1392R) was performed. Fresh
kly for the expression (%) of envelope gp20 by IFA and FACS analysis.
used as gp20 IFA controls and were found to be consistently negative
e conducted with similar results; the data in the figure are derived from
kinetics observed in both experiments: (A) CEM-SS cell infection, (B)
aji cell infection. D2/RHE/OR-infected MT-4 cells became positive by
n up to 60 days after infection (data not shown).ral clon
and re
d wee
were
ts wer
fection
nd (E) RGriffiths et al., 1997). Interestingly, all SRVs isolated from
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51POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVsumans or human cell lines that have been character-
zed to date are members of the SRV-1 serogroup.
We successfully isolated molecular clones of proviral
enomes of two serogroup 2 SRVs: D2/RHE/OR and
2/RHE/OR/V1. Restriction endonuclease mapping using
limited battery of enzymes has demonstrated that se-
ogroup 2 SRVs contain conserved restriction endonu-
lease sites in the pol gene (BamHI) and in the gag/prt
ene (EcoRI); however, a second EcoRI site present in
he pol gene in most serogroup 2 SRVs is absent from
2/RHE/OR/V1. To further distinguish between the D2/
HE/OR and D2/RHE/OR/V1 viruses, we completed the
equencing of their respective genomes.
We identified 17 amino acid residue differences be-
ween D2/RHE/OR and D2/RHE/OR/V1. Ten of these dif-
erences are found within the env gene. Of these 10, 3
ccurring at positions 302, 316, and 415 are unique to
2/RHE/OR/V1 compared with D2/RHE/OR and D2/CEL/
R; the amino acids at positions 302 (D2/RHE/OR/V1 to
2/RHE/OR or D2/CEL/OR; small, nonpolar Gly to Asp)
nd 316 (nonpolar Ile to polar Thr) represent nonconser-
ative amino acid substitutions. In addition, six residue
ifferences occurring at positions 156 (D2/RHE/OR/V1
nd D2/CEL/OR to D2/RHE/OR; Asn to Thr), 160 (Pro to
is), 296 (Phe to Ser), 404 (Ala to Thr), 455 (Leu to Phe),
nd 519 (Gly to Arg) represent nonconservative changes
etween D2/RHE/OR/V1 and D2/CEL/OR relative to D2/
HE/OR. Potential microconformational changes in-
uced by nonconservative amino acid changes may af-
ect the ability of the envelope glycoprotein to form mul-
imers in the host cell plasma membrane, alter
ecognition by the host immune response of the external
nvelope glycoprotein, or possibly affect the availability
nd function of the fusion peptide domain (Johnston et
l., 1993; Gardner and Luciw, 1989). The T cell activation
omain, as defined by env amino acid residues 233–249,
s 100% conserved among all SRV-2 isolates, including
2/MNE/WA (Malley et al., 1991). The immunosuppres-
ive peptide residing between env residues 447–472 is
dentical among all SRV serogroups with the exception of
2/RHE/OR, which predicts a Phe at position 455 (Cian-
iolo et al., 1984). Unlike lentiviral or type C retroviral
mmunodysfunction, the immunosuppressive peptide
ay not serve a major role in type D virus immunosup-
ression (Sonigo et al., 1986). The significance of the Phe
t position 455 in immunosuppression or host range in
2/RHE/OR infection is unknown. The fusion domain
ontains a hydrophobic region at the N-terminus of the
p20 (amino acid residues 383–409) followed by a series
f heptad-repeats (amino acids 410–463) and is well
onserved in all SRV serogroups (Chambers et al., 1990).
he remainder of the amino acid differences between
2/RHE/OR and D2/RHE/OR/V1 are dispersed among
he three other SRV genes: gag, prt, and pol.
All amino acid differences between D2/RHE/OR and2/RHE/OR/V1 found within the gag gene reside in the chosphoprotein pp24/pp18. This protein is the least con-
erved of those predicted by the gag sequences of all
olecular clones of SRV-2. D2/CEL/OR and D2/MNE/WA
ave been associated with retroperitoneal fibromatosis
n Celebes and pig-tailed macaques and have a nonpo-
ar Met at position 127, identical to D2/RHE/OR, but
istinct from the polar Thr present in D2/RHE/OR/V1 (Fig.
) (Giddens et al., 1985; Shiigi et al., 1986; Benveniste et
l., 1985; Stromberg et al., 1984; Marx et al., 1985; Hen-
erson et al., 1985). The potential structural differences
f these phosphoprotein gene products may result in cell
r tissue specificity in vivo that may ultimately affect the
athogenic outcome of serogroup 2 SRV infection. Re-
ently, a conserved proline-rich motif, PPPY, has been
haracterized in the C-terminal domain of the phospho-
rotein, pp16, of MPMV (Yasuda and Hunter, 1998). De-
etion mutagenesis has suggested that the PPPY motif is
ecessary for late-stage virus release from the infected
ell. In addition, the pp24 and pp16 regions outside of the
PPY motif were demonstrated to be necessary for virus
article infectivity, capsid precursor stability, and inhibi-
ion of premature viral protease activity (Yasuda and
unter, 1998). The gag p12 protein is 100% conserved
etween the molecular clones D2/RHE/OR and D2/RHE/
R/V1, but the corresponding protein in D2/CEL/OR con-
ains three nonconservative changes relative to D2/RHE/
R/V1 at positions 272 (D2/RHE/OR/V1 to D2/CEL/OR;
rg to Trp), 279 (Ile to Lys), and 293 (Ser to Pro) that
xactly match the residues found in the molecular clones
f D1/RHE/CA and MPMV. Additional studies indicate
hat the gag p12 domain may assist in MPMV capsid
ssembly and appears to be required for virion infectivity
Sommerfelt et al., 1992). Limited N-terminus amino acid
nd nucleotide sequence analyses have demonstrated
hat the D2/MNE/WA virus recovered from M. nemestrina
s very similar to, yet distinct from, the D2/CEL/OR, D2/
HE/OR, and D2/RHE/OR/V1 molecular clones within the
ag and env genes (Grant et al., 1995a, 1995b; Hender-
on et al., 1985). Notably, the matrix protein (MA) is
ompletely conserved between all the serogroup 2 SRVs
nd retains two noncontiguous regions rich in basic
mino acid residues that are conserved between all
olecularly cloned SRVs, suggesting a retention of func-
ion during viral replication (Conte et al., 1997).
The predicted D2/RHE/OR and D2/RHE/OR/V1 pro-
eases are highly related to other retroviral and cellular
roteases (Toh et al., 1985; Seiki et al., 1983; Schwartz et
l., 1983; Power et al., 1986; Katz and Skalka, 1990). The
-terminal end of D1/RHE/CA viral protease is reported
o be similar to other proteins encoding deoxyuridine-
riphosphatase (dUTPase) enzymatic activity (McGeoch,
990). Furthermore, biochemical analysis has demon-
trated the presence of dUTPase activity in the corre-
ponding region of MPMV and SRV-1 (Elder et al., 1992).
he C-terminal portion of the viral protease has signifi-
ant homology to other retroviral and cellular aspartyl
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52 MARRACCI ET AL.roteases (Toh et al., 1985; Seiki et al., 1983; Schwartz et
l., 1983; Power et al., 1986), including the presence of
he Asp-Thr-Gly active site at amino acid positions 188–
90 (data not shown) (Thayer et al., 1987; Shiigi et al.,
985). The five motifs found in the dUTPase (DU) domain
f the prt gene are well conserved among the SRV-2
olecular clones (data not shown) (McGeoch, 1990).
ithin motif 5, an acidic Asp resides at position 153 in
2/CEL/OR, whereas a polar Asn or Gln is found in
2/RHE/OR and D2/RHE/OR/V1 or D1/RHE/CA and
PMV, respectively. How this nonconserved amino acid
hange may affect the function of the dUTPase is not
lear. dUTPase functions by decreasing the cellular
UTP levels in actively dividing cells, which may other-
ise lead to misincorporation into the newly synthesized
roviral genome and development of point mutations or
trand breakage (Grafstrom et al., 1978). Moreover, feline
mmunodeficiency virus has been observed to incur a
ivefold increase in error rate over the wild-type virus
uring replication in primary macrophages if the viral
UTPase is not functional (Lerner et al., 1995). Archived
F tumor tissues, fresh tissues, and lymphocytes from M.
emestrina infected with D2/MNE/WA, collected over a
eriod of 11 years, were used by Grant et al. (1995a) to
nalyze genetic changes within the envelope gp70 do-
ain (nucleotides 144–260, which include an overlap-
ing 39orf) (1995a). Using PCR-sequence analysis tech-
iques, Grant et al. (1995a) were able to demonstrate a
emarkable stability of the genomic sequences analyzed.
hese results were consistent with our observations by
outhern analysis that repeatedly demonstrate the same
estriction endonuclease patterns for each of the sero-
roup 2 SRV isolates so far described (unpublished re-
ults). Interestingly, unlike the nonprimate lentiviruses
nd types B and D retroviruses, primate lentiviruses do
ot encode a dUTPase (Elder et al., 1992; Ko¨ppe et al.,
994: Shao et al., 1997; Wagaman et al., 1993; Turelli et
l., 1996). This high degree of genome conservation
uggests that dUTPase activity may impart a stability to
he SRV genome that may be absent in the primate
entiviruses that exhibit a higher degree of genetic vari-
bility.
The D2/RHE/OR virus was initially observed and iso-
ated from group-housed rhesus macaques exhibiting
ild symptoms of SAIDS. A restriction endonuclease site
ariant, D2/RHE/OR/V1, was recovered and identified
rom rhesus macaques endemically infected with D2/
HE/OR but exhibiting more severe symptoms and a
igher mortality rate. Whether the presence of D2/RHE/
R/V1 was secondary to an evolutionary process or the
esult of an independent virus transmission event has
ot been determined. However, a correlation existed
etween the appearance of severe immunodeficiency
isease and recovery of the variant virus genotype. Initial
n vitro tropism analyses identified differences in the
bility of D2/RHE/OR and D2/RHE/OR/V1 to infect target eells, as defined by the use of cell-free inocula to infect
aji and Hut78 cells. In these initial in vitro experiments,
ell-free D2/RHE/OR/V1, but not cell-free D2/RHE/OR,
eadily infected Hut78 cells. Moreover, infection of Hut78
ells was established by cell-to-cell transmission of
ut78 cells and rhesus peripheral blood leukocytes in-
ected with D2/RHE/OR or D2/RHE/OR/V1 (M. Axthelm,
ersonal communication). Both D2/RHE/OR and D2/
HE/OR/V1 isolates are able to readily infect Raji cells.
ifferences between in vitro and in vivo cell tropism have
een identified within different isolates of the serogroup
SRVs (Yetz and Letvin, 1987; van Kuyk et al., 1991; Maul
t al., 1988; Legrand et al., 1985) and may correlate with
ifferences observed in pathogenic outcome after infec-
ion with D1/RHE/CA or D1/CYC/NE (Power et al., 1986;
arx et al., 1984; Letvin et al., 1983, 1984; Desrosiers et
l., 1985; Daniel et al., 1984). In vitro correlates of patho-
enesis have been strongly associated with env gene
iversity in both the simian and human immunodefi-
iency viruses (York-Higgins et al., 1990; Cheng-Mayer et
l., 1990; Cann et al., 1992; Toohey et al., 1995; Lane et al.,
995; Kodama et al., 1993; Mori et al., 1993; Sharma et al.,
992; Rudensey et al., 1998). Specifically, virus obtained
t different stages of disease progression may be en-
iched for an isolate displaying a unique cell tropic,
eplicative, or cytopathic phenotype in vitro (Anderson et
l., 1993; Schuitemaker et al., 1992; Fenyo¨ et al., 1988;
ersmette et al., 1989; Cheng-Mayer et al., 1988; Åsjo¨ et
l., 1986).
Cell-free infection of T and B cell lines has demon-
trated that viral determinants of SRV host range may be
ultifactorial and dependent on genetic domains con-
ained outside of the env gene. Interestingly, p59V1392R-
nfected CEM-SS and SupT1 cells appeared to release
irus particles in a manner equivalent to D2/RHE/OR/V1,
uggesting that this function was dictated by determi-
ants contained in the 59 genomic fragment. Moreover,
592R39V1-infected CEM-SS and SupT1 cells released
irus particles congruent with D2/RHE/OR infection in
he same cell lines, further supporting the hypothesis
hat virus particle release is determined by the 59 domain
f the genome. Interestingly, the appearance of syncytia
orrelates solely with the envelope gene expressed; D2/
HE/OR- and p59V1392R-infected cultures exhibit very
ew and very small syncytia. In contrast, D2/RHE/OR/V1-
nd p592R39V1-infected cultures display numerous large,
allooning syncytial structures. The relative capacity to
nduce syncytia may correlate with the efficiency of cell-
o-cell transmission of the virus and spread of infection.
Our data suggest a model in which host range may be
etermined by the ability of the simian retrovirus to effi-
iently release and spread throughout a cell culture via
fusion from without” and “fusion from within” mecha-
isms of transmission. D2/RHE/OR/V1 virus is fully com-
etent and can spread infection throughout a culture
ither by high-titer virion release (fusion from without) in
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53POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVsupT1 and CEM-SS infections or by cell-to-cell spread
fusion from within) as observed in the Hut78 and MT-4
nfections. Therefore, in cell lines in which virus release
s hindered, the spread of infection may rely more heavily
n cell-to-cell mechanisms. In contrast, virus infection of
ell lines that support high levels of virus release may
ot be as dependent on cell-associated mechanisms for
pread of infection. Productive infection by D2/RHE/OR
eems to be limited to Raji, SupT1, and CEM-SS cells,
uggesting that host-specific factors may also play a role
n determining tropism. The ability of D2/RHE/OR to pro-
uctively infect Hut78 cells has been stochastic (2 in 12
nfection attempts) and has succeeded only after pro-
onged culture periods sometimes exceeding 60 days.
he role of titer as a factor in the ability to infect Hut78
ells cannot be ruled out. Although equal amounts of
everse transcriptase activity were applied to each cul-
ure, the syncytia forming capacities of each inocula
ere not equivalent (data not shown). Interestingly, de-
ayed onset of infection also appears to occur with D2/
HE/OR infection of MT-4 cells; productive infection of
T-4 cells with D2/RHE/OR occurs only after prolonged
ulture (.38 days). In vitro propagation and infection
nalyses of D2/RHE/OR revealed a low titer of released
irions that seems to be influenced by the specific cell
nfected. Therefore, host range is affected by both env
nd non-env viral determinants; additionally, host factors
ay be necessary for interaction with both the envelope
lycoprotein in facilitation of virus–cell and cell–cell
embrane fusion and the gag pp18 in promotion of viral
elease and infectivity.
The in vitro kinetics of D2/RHE/OR infection, as de-
ined by time required to achieve complete or near-
omplete virus spread, appears to be dependent on the
pecific T cell population infected. In vivo, some ma-
aque T cell subsets may be less readily infected by
2/RHE/OR; these cells may express a low, almost un-
etectable level of virus that (1) are still functional and (2)
scape removal by host-induced mechanisms. This low-
evel infection may be the result of the delicate balance
etween progression toward virulent infection and main-
enance of host immune functions. In contrast, the in-
reased replicative capacity of D2/RHE/OR/V1 may re-
ult in greater dysfunction of the immune system. Studies
n animals will be necessary to determine the pathoge-
icity of these SRV-2 molecular clones.
MATERIALS AND METHODS
ells and virus
All Raji and T cell lines (CEM-SS, Hut78, MT-4, and
upT-1) were grown in RPMI 1640 supplemented with
0% heat-inactivated FCS and 1% penicillin, neomycin,
treptomycin, and L-glutamine. Canine D17 cells were
rown in MEM supplemented with 10% heat-inactivated
CS and 1% penicillin, neomycin, streptomycin, L-glu- damine, and nonessential amino acids. Suspension cul-
ures were split-passaged twice weekly at a ratio of 1:10
n 10 ml of fresh media. The D17 cells were split at a ratio
f 1:10 once per week and fed with 10 ml of fresh MEM
nce per week.
olecular cloning of the full-length D2/RHE/OR/V1
enome
Genomic DNA was prepared from Raji cells that had
een cocultivated with peripheral blood lymphocytes
rom a virus-infected rhesus macaque (ORPRC animal
05-08544). The DNA exhibited a restriction endonucle-
se pattern representative of D2/RHE/OR/V1 and was
sed for construction of genomic DNA libraries (unpub-
ished data).
The library was constructed using partial Sau3A-1
igested DNA fragments (enriched for 9- to 21-kb frag-
ents) ligated to EMBL3 arms (Stratagene, La Jolla, CA)
nd packaged with Gigapack II Gold (Stratagene). Using
ethods previously described in the analysis of D2/
HE/OR (Marracci et al., 1995), the library was plated,
ransferred to nitrocellulose membranes, and screened
y high-stringency hybridization with 32P-labeled p8A-1
recombinant plasmid containing the complete D2/
EL/OR genome). Posthybridization washes were highly
tringent and followed wash parameters previously de-
cribed in the library screening for D2/RHE/OR (Marracci
t al., 1995). Positive clones were initially examined for
he presence of 59 LTR, 39 LTR, gag, and env gene
equences by PCR (see below) to identify candidate
lones with the highest likelihood of containing full-
ength SRV genomes. Phage DNA prepared by the plate
ysate procedure (Ausubel et al., 1987) were digested
ith restriction endonucleases to identify full-length
lones with the D2/RHE/OR/V1 restriction map pattern.
hree clones were identified as containing the full-length
2/RHE/OR/V1 genome; one clone (11B-V1) was demon-
trated to be infectious and was selected for further
haracterization. The construction of the D2/RHE/OR mo-
ecular clone has been described previously (Marracci et
l., 1995).
CR identification of candidate lambda clones
ontaining potentially full-length D2/RHE/OR/V1
enomes
Phage were eluted from positive plaques (in 100 ml
olume) and were subsequently filtered and heated to
00°C for 15 min to disrupt capsids; DNA extract was
hen clarified from debris by brief centrifugation. PCR
sing phage DNA (3 ml) as template was conducted as
reviously described (Pilcher et al., 1994). PCR was con-
ucted using chimeric virus plasmid DNA (1–3 ml) as
emplate in a core buffer consisting of 20 mM Tris–HCl
pH 8.4), 50 mM KCl, 200 mM concentration of each
NTP, 100 pmol of each primer, and 2.5 units of Taq DNA
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54 MARRACCI ET AL.olymerase. The reaction mixture was subjected to an
nitial denaturation at 95°C for 1 min, followed by 30
ycles of 93°C for 40 s, 55°C for 1.5 min, and 73°C for
5 s. A final extension at 70°C for 10 min was performed
ollowed by a 4°C soak. The forward and reverse primers
sed to confirm the presence of the full-length viral
enomes were 20-mers (FGM1, nucleotides 4364–4383:
9-TTTTGGACTTGAACCATCCA-39; RGM1, nucleotides
818–4799: 59-ATTTTGCCGTGTCTGAGATA-39). These
rimer sets were based on consensus sequences found
ithin D2/RHE/OR/V1, D2/CEL/OR, and D2/RHE/OR.
NA isolation and sequencing of D2/RHE/OR
nd D2/RHE/OR/V1 molecular clones
The 15-kb HindIII restriction fragment containing the
ntire D2/RHE/OR/VI genome, including flanking human
equences, was subcloned into pBR322. The resulting
ecombinant is designated pV1. Standard methods of
ransformation into DH5a cells, alkaline lysis, and ce-
ium chloride gradient purification of plasmid DNA (Aus-
bel et al., 1987) were used to prepare plasmid DNA for
ideoxynucleotide sequence analysis and for transfec-
ions. The D2/RHE/OR and D2/RHE/OR/V1 envelope
enes and 39 LTR regions were sequenced using the
equenase version 2.0 kit (United States Biochemical
orp., Cleveland, OH). The remainder of the D2/RHE/OR
nd D2/RHE/OR/V1 genomes were sequenced using the
erkin-Elmer Cetus/Applied Biosystems (Foster City, CA)
utomated sequencer (373 DNA Sequencer Stretch). Se-
ogroup 2-specific oligonucleotides for primer walking
ere synthesized at the ORPRC Molecular Biology Core
acility. Sequence was confirmed in both directions.
ransfection of D2/RHE/OR/V1 molecular clone
Canine D-17 cells were transfected with 4 mg of
1B-V1 (recombinant lambda clone) DNA or 4 mg of pV1
recombinant plasmid clone) DNA using the calcium
hosphate procedure (Ausubel et al., 1987). Mock trans-
ections using calcium phosphate precipitate without
NA were also conducted. After 24 h, Raji cells (105)
ere added to the D-17 transfectant cultures and cocul-
ivated for an additional 4 days. The Raji cells were then
arvested and cultured independently. In addition, the
ulture medium was filtered (0.45 mm) and added to
ninfected Raji cells to verify the existence and trans-
issibility of cell-free infectious virus. The cultures were
assaged (1:10 split ratio, twice weekly) until they tested
ositive for virus production.
mmunofluorescence detection of simian retrovirus
ntigens expressed in infected cells
For transfection analyses, at 2–4 weeks post-transfec-
ion, gp20 immunofluorescence assays (IFA) were per-
ormed on uninfected Raji cells, control SRV-2-infected
aji cells, and Raji cells subjected to cocultivation with cransfected D-17 cells and virus rescue. In addition, other
ell lines, either directly infected with cell-free virus prep-
rations or cocultivated with single-cell suspensions of
issues obtained from infected macaques, were sub-
ected to IFA. Cells were fixed in 50% ethanol (190 proof)
n Dulbecco’s PBS (no Ca21 or Mg21). A mouse anti-gp20
onoclonal antibody isolated from ascites fluid (ob-
ained from Dr. Niels Pederson, University of California at
avis) and goat F(ab9)2 anti-mouse IgG (H&L chain) flu-
rescein isothiocyanate (FITC) (Tago Biosource Interna-
ional, Camarillo, CA) were used to detect SRV-infected
ells. In addition, serogroup-specificity of the transmitted
RV was determined by membrane IFA on unfixed cells
sing negative control monkey serum or monkey anti-
erum specific for SRV-1, SRV-2, or SRV-5, with subse-
uent labeling with goat anti-monkey IgG-FITC. The mon-
ey anti-SRV serum recognizes predominantly env- and
ag-related antigens (Shiigi et al., 1989); thus in the case
f unfixed SRV-infected cells, the major target would be
he env-encoded antigen gp70. For infection analyses,
p20 IFAs were performed on uninfected Raji, Hut78,
EM-SS, MT-4, and SupT-1 cells and on cells infected
ith molecularly cloned D2/RHE/OR and D2/RHE/OR/V1
irus and corresponding chimeric viruses. In all cases,
tained cells were then analyzed on an EPICS C flow
ytometer (Coulter Electronics, Miami Lake, FL).
estriction digest and Southern analysis of genomic
NA from infected Raji cells
Genomic DNA was isolated and digested with restric-
ion enzymes (SphI, BamHI, EcoRI, and HindIII) to verify
he identity of the integrating virus. DNA digestion, trans-
er of nucleic acids to nylon membranes, prehybridiza-
ion, hybridization, and posthybridization washes were
onducted using previously described methods (Mar-
acci et al., 1995). Hybridizations (.106 cpm/ml) were
onducted with the full-length SRV-2 (p8A-1; D2/CEL/OR)
robe overnight at 37°C. Posthybridization washes were
onducted with 23 SSC/1.0% SDS for 15 min at room
emperature (two or three times), 23 SSC/1.0% SDS for
5 min at 65°C (once), and 0.23 SSC/1.0% SDS for 15 min
t 65°C (one to three times). Autoradiography was con-
ucted overnight with an intensifying screen at 286°C.
onstruction of the p592R39V1 chimera
A serogroup 2 SRV chimera was constructed by using
conserved BamHI restriction endonuclease site found
t position 4593 in the pol gene. This chimera contains
he 59 half of D2/RHE/OR and 39 half of D2/RHE/OR/V1,
elative to the BamHI site. The pV1 plasmid, containing
he full-length D2/RHE/OR/V1 genome, was digested
ith BamHI; a 10-kb fragment containing the env gene
nd all downstream sequence including vector was re-
igated to construct the p39V1 subgenomic molecular
lone. After digestion of p39V1 and a second recombi-
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55POLYMORPHIC VARIANTS OF TYPE D SEROGROUP 2 SRVsant J450 (containing D2/RHE/OR sequence upstream of
he unique BamHI site) with BamHI and SalI, an ;10-kb
nv-containing fragment from p39V1 was ligated with the
.6-kb J450 upstream fragment. Initial screening for full-
ength clones was conducted by PCR. Additional verifi-
ation of the chimeric virus clones was achieved by
estriction endonuclease digestion and sequence anal-
ses. The infectivity of the verified chimeric virus was
hen confirmed by transfection onto D17 cells, followed
y cocultivation with permissive Raji cells at 24 h post-
ransfection. After 4 days of additional culture, the Raji
ells were removed and cultured independently. Concur-
ently, the culture medium was filtered (0.45 mm) and
pplied to fresh Raji cells to determine the infectious
ature of cell-free virions.
onstruction of the p59V1392R chimera
The construction of the reciprocal SRV chimera was
lso completed by ligating the 59 half of D2/RHE/OR/V1
nd 39 half of D2/RHE/OR relative to the unique BamHI
estriction site found in the pol gene. To use this BamHI
estriction site, the plasmid pBR322 was modified to
ontain a BglII restriction endonuclease site. pBR322
as digested with SalI and subsequently treated with T4
NA polymerase to fill in the ends. After ligation with
glII linkers and removal of concatamerized linkers by
igestion with BglII, the linearized DNA was subse-
uently purified and religated. The recovered plasmid
as designated pBRSaBg. pBRSaBg was digested com-
letely with BamHI and BglII, and the resulting ends
ere dephosphorylated by treatment with calf intestinal
hosphatase to prevent recircularization of vector DNA.
he pV1 molecular clone, containing the complete D2/
HE/OR/V1 viral genome, was concurrently digested
ith BamHI; the resulting 5.5-kb fragment that contains
he complete 59 portion of the genome upstream of the
nique BamHI site was gel-purified and ligated to the
repared plasmid vector. A recovered recombinant with
orrect insert orientation (pBRSaBg5V1) was selected for
urther analysis. pBRSaBg5V1 was then digested with
amHI and ligated with a second BamHI fragment that
ontained the 39 portion of the D2/RHE/OR genome. The
erification of this chimera was conducted by restriction
ndonuclease digestion with EcoRI and SphI, PCR am-
lification using primers flanking the BamHI site, and
equence analysis. Plasmid DNA was prepared, and the
nfectivity of the p59V1392R chimera was confirmed by
ransfection of D17 cells as described above.
everse transcriptase assay
D2/RHE/OR-, D2/RHE/OR/V1-, and chimeric virus-in-
ected Raji cells were cocultivated with uninfected Raji
ells daily for up to 7 days; culture fluids were collected
aily from days 4–7, and a reverse transcriptase (RT)
ssay was performed to determine the day of peak RT activity. Supernatants from infected cultures were filtered
0.45 mm); 1 ml was used for the RT assay and the
emainder was stored at 4°C for use in the infection
ssays. The culture medium containing the peak value of
T activity was used as the inoculum in the infection
ssay. The virus was pelleted by centrifugation, and the
upernatant was discarded (TLA-45 rotor in a Beckman
ptima TL Ultracentrifuge, 4°C, 45,000 rpm, 10 min).
irus pellets were stored at 4°C until all samples could
e processed simultaneously. The virus was resus-
ended in 25 ml of lysis buffer (1% Nonidet P-40 in TE)
nd allowed to lyse for 30 min on ice. The RT assay
eaction mixture was added to the lysed pellets and
ncubated at 37°C for 1 h in a shaking water bath [25 ml
f 43 reaction buffer (20 mM MgCl2, 200 mM KCl, 24 mM
TT, 300 mM Tris, pH 8.0, 0.4 mg/ml BSA); 40 ml of
repared RNA template heated to 42°C for 5 min and
ooled slowly to room temperature before use (Pharma-
ia, 1 unit/ml); [3H]thymidine 59triphosphate (5000 mCi/
000 ml, 2.5 ml/sample dried and resuspended in 10 ml
ater/sample]. The samples were then precipitated in 2
l of ice-cold 10% TCA (with 0.02 M sodium pyrophos-
hate) and 10 ml of yeast tRNA/tube (10 mg/ml) for 20 min
n ice. The incorporated counts were collected on glass
ilters and counted in 5 ml of scintillation fluid for a
uration of 1 min/sample.
nfection of Raji and T cell cultures with equivalent
nput viruses as determined by RT assay
Filtered viral collections were applied to uninfected
aji or T cell lines at equivalent input virus amounts (RT
pm/cell). The final volume of virus inoculum was ad-
usted by the addition of fresh RPMI medium with a final
ell number of 1 3 105. Cultures were analyzed weekly
eginning at 10 days postinfection; culture fluids were
emoved, filtered (0.45 mm), and stored at 286°C. Cells
ere retained for an IFA analysis using anti-gp20 mono-
lonal antibody to determine the infection status of the
ultures. The cultures were then allowed to propagate
ntil all cultures were positive by anti-gp20 IFA analysis
r until 60 days had passed.
ucleotide sequence accession numbers
The GenBank accession number for the complete D2/
HE/OR/V1 and D2/RHE/OR sequences are AF126468
nd AF126467, respectively. Note that the D2/RHE/OR
nvelope and 39 LTR sequences have been previously
ublished by our laboratory (Marracci et al., 1995) and
re also available at GenBank accession number
38695.
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